The global cell culture media, sera, and reagents market was valued at US$ 4.9 Bn in 2022 and is anticipated to expand at a CAGR of 5.7% from 2022 to 2030.
The global cell culture media, sera, and reagents market was valued at US$ 4.9 Bn in 2022 and is anticipated to expand at a CAGR of 5.7% from 2022 to 2030
The global cell culture media, sera, and reagents market for the historical period 2017–2018 and forecast period 2022–2030, contract research and manufacturing, and focus on stem cell research would expand the scope of cell culture,growing demand for biopharmaceuticals and artificial organs, and trend towards serum-free, specialty and customized media solutions are projected to drive the global cell culture media, sera, and reagents market during the forecast period
Download Sample @ https://qyresearchmedical.com/sample/111579
Contract research and manufacturing, and focus on stem cell research would expand the scope of cell culture: Key Drivers
Cell culture technology is applied in various sectors such as research, academics, bioprocessing and manufacturing, cell therapy, and regenerative medicines. Leading pharmaceutical companies are now expanding their capabilities into biopharmaceutical manufacturing in order to leverage high market potential and growing demand for these products.
This has led to a blurring distinction between biotechnology and pharmaceutical companies. Biotech companies are increasingly focusing on entering into alliances with big pharma players that lack the expertise in highly specialized treatment areas such as personalized medicine.
The cell culture media, sera and reagents market is witnessing a shift towards contract manufacturing and research, primarily due to the huge capital investment involved and specificity of each biomanufacturing process. For instance, cell cultures could be 2D, 3D, rotating, continuously stirred, batch-fed, and several other types. This requires advanced capabilities in terms of capital, equipment, and resources, hence contract manufacturing presents an economically beneficial solution.
The expanding scope of cell culture into areas such as stem cell research is also responsible for the impressive market growth. The growing importance of stem cell therapy is underlined by the fact that these therapies help treat the cause of the disease, while conventional treatment methods help in managing only the symptoms.
Cell culture helps in standardizing the production and differentiation process of stem cells, thereby enabling their commercial use. Favorable governmental regulations such as lifting of the ban on federal funding for human embryonic stem cell research in the U.S. in 2009 had accelerated the development of novel processes for treating the diseases that remain untreated to date or have limited therapeutic options.
Stringent Process Controls Require Advanced Manufacturing Capabilities and Capacities to Hamper Market
The process of cell culture involves numerous stages that are strictly monitored for various parameters including temperature, humidity, nutrients, surface area, aeration, toxins and contamination.
The technique requires precise handling of all the components as any deviation could have an impact on the efficacy of the final products such as cell line, tissue, organ or a biomolecule. This necessitates the use of strict control systems leading to increase in the total cost of development and manufacturing.
Such constraints could lead to a bottleneck in the progress and development of cell culture techniques, thereby restraining market growth.
Global Cell culture media, sera, and reagents Market: Competitive Landscape
This report profiles major players in the global cell culture media, sera, and reagents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global cell culture media, sera, and reagents market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global cell culture media, sera, and reagents market are
- Sigma-Aldrich Corporation
- BD Biosciences
- EMD Millipore
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- Lonza Biosciences
- VWR International
- and Corning incorporated
- Eppendorf AG.
- HiMedia Laboratories
- WuXi AppTec
- Sumitomo Bakelite Co., Ltd.
- PAA Laboratories
- PromoCell GmbH
- and Takara Bio, Inc.
- among others
Global Cell culture media, sera, and reagents Market: Key Developments
Key players in the global cell culture media, sera, and reagents market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cell culture media, sera, and reagents market. A few expansion strategies adopted by players operating in the global cell culture media, sera, and reagents market are:
In May 2015, Lonza Group and Nikon Corporation announced an exclusive collaboration in the field of cell and gene therapy manufacturing in Japan. Under the terms of the agreement, Nikon will have access to Lonza’s quality and operating systems, facility design and ongoing consulting services for the establishment of a wholly owned Nikon cell and gene therapy contract manufacturing business.
In February 2015, EMD Millipore announced an exclusive agreement with Precision Biologics, Inc. to provide upstream process development services. Under the terms of the agreement, EMD Millipore will provide process development through its Provantage services offering, at its bio development center in Martillac, France.
The report on the global cell culture media, sera, and reagents market discussed individual strategies, followed by company profiles of manufacturers of cell culture media, sera, and reagents. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cell culture media, sera, and reagents market.
Key Questions Answered in Global Cell Culture Media, Sera and Reagents Market Report
- What is the scope of growth of product companies in the global Cell Culture Media, Sera and Reagents market?
- What will be the Y-o-Y growth of the global Cell Culture Media, Sera and Reagents market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global Cell Culture Media, Sera and Reagents market?
- Will North America continue to be the most profitable market for Cell Culture Media, Sera and Reagents providers?
- Which factors are anticipated to hamper the growth of the global Cell Culture Media, Sera and Reagents market during the forecast period?
- Which are the leading companies in the global Cell Culture Media, Sera and Reagents market?
Global Cell Culture Media, Sera and Reagents Market – Segmentation
Media Type
- Chemically-defined
- Classical
- LB
- Protein-free
- Serum-free
- Specialty
Sera
- Fetal Bovine
- Newborn calf and adult bovine
- Specialty
Reagents
- Albumin
- Amino acids
- Attachment factors
- Growth Factors & Cytokines
- Protease Inhibitors
- Specialty
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111579/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/